RedHill Biopharma Ltd. (NASDAQ: RDHL) announced it has acquired exclusive commercialization rights to two FDA-approved gastrointestinal drugs, Rebyota and Clenpiq ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions